Hy Hybrid

Cheese


Overview:

Named for its sharply sour aroma, Cheese is an indica-dominant hybrid from the U.K. that has achieved widespread popularity for its unique flavor and consistent potency. With origins that stretch back to the late 1980s, Cheese is said to descend from a Skunk #1 phenotype whose pungent aroma made it stand out. Breeders like Big Buddha Seeds later introduced Afghani indica genetics to increase Cheese’s trichome production and yields. The resulting hybrid is now well-known for its relaxed, happy effects that gently ease you into a blissful state of mind.

Strain Attributes:

Effects

Euphoric

Happy

Hungry

Relaxed

Uplifted

Euphoric

Happy

Hungry

Relaxed

Uplifted

Medical Uses

Depression

Headaches

Insomnia

Pain

Stress

Depression

Headaches

Insomnia

Pain

Stress

Negatives

Dizzy

Dry Eyes

Dry Mouth

Headache

Paranoid

Dizzy

Dry Eyes

Dry Mouth

Headache

Paranoid


Rate this Strain!

SPONSORS


FROM OUR BLOG


News

US Consumers Have Spent Over $4,000,000,000 on This One Cannabis Product - What Is It?

Flower reigns supreme, whether buying it as buds and flowers or having those buds and flowers pre-rolled into joints for you, smoking cannabis is still the king according to a new industry study! With customer tastes changing toward convenience and ready-to-use products, pre-rolled joints have transformed from a niche product to a retail mainstay, quickly becoming one of the cannabis industry's fastest-growing segments.
Medical

Forget Brain Quizzes, Cannabis Could be the Key to Preventing Cognitive Decline Says New Groundbreaking Study

According to the findings, the individuals who historically consumed cannabis occasionally had the best results. They also added that frequent marijuana consumption was not linked to a decrease in cognitive performance during the trial.
News

Why Did Big Tobacco Buy the Most Advanced Medical Marijuana Inhaler Company for $650,000,000?

The potential acquisition of Syqe Medical by Phillip Morris represents a significant strategic move for the tobacco giant, signaling its entry into the flourishing marijuana industry. With an initial investment of $130 million to support Syqe's FDA approval process, followed by a possible $650 million acquisition, this deal can potentially make Syqe one of the largest cannabis companies globally. Moreover, Syqe's innovative inhaler, utilizing raw cannabis inflorescence, could secure FDA approval, positioning the company as a trailblazer in the medical cannabis sector.